|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Treatment of early stage non-small cell lung cancer显示文摘 | Mathur PN Edell E Sutedja T | 2003 | Chest2003，123，1： | 1 |
| 2 | Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents 显示文摘 | Bolliger CT Sutedja TG Strausz J | 2006 | Eur Respir J2006，27，6： | 1 |
| 3 | Endobronchial electro cautery is an excellent alternative for Nd; YAG Laser to treat airway tumors显示文摘 | van Boxem TJ Schramel FM | 1997 | J Bronchol1997，4，1： | 1 |
| 4 | Therapeutic bronchoscopy with immediate effect:laser,electrocautery,Argon plasma coagulation and stents显示文摘 | Bolliger CT Sutedja TG Strausz J | | 0，，06： | 1 |
| 5 | Autofluorescencebronchoscopy improves staging of radiographically occult lungcancer and has an impact on therapeutic strategy显示文摘 | Sutedja TG Codrington H Risse EK | 2001 | Chest2001，120，4： | 1 |
| 6 | Lifetime occupation, education, smoking, and risk of ALS 显示文摘 | Sutedja NA Veldink JH Fischer K | 2007 | Neurology2007，69，15： | 1 |
| 7 | Elevated hTERT mRNA levels: a potential determinant of bronchial squamous cell carcinoma(in situ) 显示文摘 | Snijders PJ Breuer RH Sutedja TG | 2004 | Int J Cancer2004，109，3： | 1 |
| 8 | Expressionof the p16 ( INK4a ) gene product, methylation of the p16 (INK4a) promoter region and expression of the polycomb- group gene Bmi - 1 in squamous cell lung carcinoma and premalignant endobronehial lesions 显示文摘 | Breuer RH Snijders PJ Sutedja GT | 2005 | Lung Cancer2005，48，3： | 1 |
| 9 | New techniques for early detection of lung cancer显示文摘 | Sutedja G | 2003 | Eur Respir J Suppl2003，39，1： | 1 |
| 10 | Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents 显示文摘 | BOLLIGER CT SUTEDJA TG STRAUSZ J | 2006 | Eur Respir J2006，27，6： | 1 |
| 11 | Tracheobronchial stenting in the terminal care of cancer patients with central airways obstruction显示文摘 | Vonk-Noordegraaf A Postmus PE Sutedja TG | 2001 | Chest2001，120，6： | 1 |
| 12 | Autofiuorescence bronchoscopy improves staging of radiographically occult lung cancer and has an impact on therapeutic strategy 显示文摘 | Sutedja TG Codrington H Risse EK | 2001 | Chest2001，120，4： | 1 |
| 13 | Outcome of lamivudine-resistant hepatitis B virus is generally benign except in cirrhotics显示文摘AIM: We set to determine factors that determine clinical severity after the development of resistance.METHODS: Thirty-five Asian patients with genotypic lamivudine resistance were analyzed in three groups:13/35 (37%) were non-cirrhotics with normal pre-treatment ALT (Group IA), 12/35 (34%) were non-cirrhotics with elevated pre-treatment ALT (Group IB), and 10/35 (29%)were cirrhotics (Group Ⅱ). Patients were followed for a median of 98 wk (range 26-220) after the emergence of genotypic resistance.RESULTS: Group IA patients tended to retain normal ALT.Group IB patients showed initial improvement of ALT with lamivudine but 9/12 patients (75%) developed abnormal ALT subsequently. On follow-up however, this persisted in only 33%. Group Ⅱ patients also showed improvement while on treatment, but they deteriorated with the emergence of resistance with 30% death from decompensated liver disease. Pretreatment ALT levels and CPT score (in the cirrhotic group) were predictive of clinical resistance and correlated with peak ALT levels and CPT score.CONCLUSION: The phenotype of lamivudine-resistant HBV correlated with the pretreatment phenotype. The clinical course was generally benign in non-cirrhotics.However, cirrhotics had a high risk of progression and death (30%) with the development of lamivudine resistance. | Yock-Young Dan Chun-Tao Wai Yin-Mei Lee Dede Selamat Sutedja Bee-Leng Seer Seng-Gee Lim | 2005 | World Journal of Gastroenterology2005，11，28： | 1 |
| 14 | Early proximallung cancer diagnosis and treatment 显示文摘 | MCWILLIAMS A LAM B SUTEDJA T | 2009 | Eur Respir J2009，33，3： | 1 |
| 15 | lncreased expression of the EZH2 polycomb group gene in Bmi-1-positive neoplastic cells during bronchial carcinogenesis显示文摘 | Breuer RH SP Smit EF Sutedja TC | 2004 | Neoplasia2004，6，6： | 1 |
| 16 | Tracheobronchial stenting in the terminal care of cancer patients with central airways obstruction显示文摘 | Vonk2Noordegraaf A Postmus PE Sutedja TG | 2007 | Chest2007，120，： | 1 |
| 17 | Therapeutic bron- choscopy with immediate effect: laser, electrocautery, argon plas- ma coagulation and stents 显示文摘 | BOLLIGER CT SUTEDJA TG STRAUSZ J | 2006 | Eur Respir J2006，27，6： | 1 |
| 18 | Expression of the p16 (INK4a) gene product,methylation of the pl6(INK4a) promoter region and expression of the polyoomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions显示文摘 | Snijders PJ Sutedja GT | 2005 | Lung Cancer2005，48，3： | 1 |
| 19 | Tracheobronchial stent2ing in the terminal care of cancer patients with central airways obstruction显示文摘 | Vonk2Noordegraaf A Postmus PE Sutedja TG | 2005 | Chest2005，120，： | 1 |
| 20 | Treatment of early stage non-small cell lung cancer显示文摘 | Mathur PN Edell E Sutedja T | | 0，，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员